Abstract: Learning Objectives: Noninvasive ventilation (NIV) is a critical resource for patients in respiratory distress. In our PICU, NIV masks were the most frequent cause of pressure ulcers (PU). Identified risk factors for PUs in this population included limited selection of masks, length of time on NIV, and variable pressure applied to the face dependent upon ventilator type. Dual and single limb circuit ventilators were both available for NIV in the PICU. Dual limb circuit ventilators were primarily utilized for NIV due to convenience. These ventilators had limited leak compensation resulting in discontinuation of positive pressure delivery when a leak developed around the mask. Single limb circuit ventilators had improved leak compensation resulting in decreased pressure necessary on the face for adequate positive pressure delivery. The aim of this quality improvement (QI) project was to decrease the incidence of PUs related to NIV masks by converting to single limb circuit NIV. Methods: The setting was a single center tertiary care PICU. Pre-Intervention data were collected from January 1, 2014-June 30, 2014 and postintervention data from July 1, 2014-June 30, 2015.The PU prevention bundle was unchanged throughout the data collection period. Primary outcome measure followed was incidence of PUs > stage II related to NIV per hundred NIV days. The primary process measure was fraction of patients with single limb circuit ventilators used for NIV. Results: The pre-intervention PU rate was 2.1. Post-intervention aggregate rate was 0.35. After a three month run in period, 100% of eligible patients were on single limb circuit ventilators for NIV. PU rate fell to zero when compliance with the intervention increased to 100%. Also, NIV days continued to increase throughout the project period. Conclusions: Implementation of single limb circuit ventilator usage in patients requiring NIV in the PICU resulted in a significant decrease of NIV related PUs despite increased usage of NIV. 
intervention group, but the reduction was not significant (p=.06). Patients who developed HAPUs had 2.5 times longer LOS (p<.001) and lower Braden scores (p<.001). No other demographic or treatment factors were predictors. For those with Braden scores of 14 or less, the odds ratio for developing a HAPU was 4.4 (CI 1.5-12.8). Conclusions: While no statistical significance was found for HAPU development between groups, implementing a critical care specific PUP Bundle had clinically significant results in this pilot study. Implementing the PUP Bundle in the critically ill with Braden scores of 14 or less may be an important intervention for HAPU prevention. Author(s): Mahramus T., Bartlett V., Brown J., Gil M., Knicely M., Niederhauser T., Penoyer D.
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Abstract: Learning Objectives: Respiratory care device (RD) use is associated with pressure ulcers (PU) and is often used in critical care. Variation in skin assessments, prevention, and treatment of PUs exists. In response to a rise in RD-PUs, a multidisciplinary team designed a respiratory therapist (RT) and nurse (RN) collaborative intervention of skin assessment, documentation, prevention, and treatment for RD-PUs. Hypothesis: Implementing the collaborative intervention will enhance awareness and collaboration of RD-PU prevention strategies across disciplines and result in fewer RD-PUs. Methods: A prospective, descriptive design in two critical care units was used to assess feasibility of the collaborative intervention, consisting of documentation under RDs and initiation of a care plan to prevent and treat RD-PUs. Audits of the medical record (EMR) were done to determine compliance with the intervention. Satisfaction and perceptions by RTs and RNs was assessed. Incident reports were used to assess RD-HAPUs before and after. Results: We performed 736 documentation audits to assess compliance with the intervention. Seventy seven satisfaction surveys were completed. The collaborative skin assessment was documented only 30% in the EMR, but the survey data indicated that RTs and RNs enjoyed performing the collaborative skin assessment together and considered it best practice to identify and prevent RD-PUs. Participants recommended that a documentation section be added to the EMR to help communicate skin assessment findings between disciplines. Timing the collaborative skin assessment was a barrier to performance. Only one RD-PU was reported during the pilot study. Conclusions: Enhanced awareness of the need to assess skin under RDs and increased collaboration between RTs and RNs during the pilot study period. While compliance with documentation was low, participants recommended to continue the collaborative intervention, add documentation sections in the EMR for RD-PU assessments, protocol orders for skin alterations, and to reposition the endotracheal tube every 24 hr vs. 48 hr. ( Tickle, 2015 ) of the use of a topical haemoglobin spray plus standard care in 18 patients with pressure ulcers showed that, following 4 weeks of treatment, the wound size reduced in 17 wounds and there was a progression toward healing in all 18. All but one of the wounds were over 2 months in duration at baseline. This article reports the results of the healing rates at 3 months of the 11 patients who continued to be treated with the haemoglobin spray. Nine of the 11 wounds healed, and 2 reduced in size by week 12 (i.e. 1 wound reduced from 30 cm(2) at baseline to 7 cm(2), while the other reduced from 6 cm(2) to 4 cm(2)). Of the 10 patients who were experiencing wound pain at baseline, 9 were pain free by week 8. Rapid elimination of slough was observed in all patients. The 82% healing rate achieved at 3 months and the fact that most patients continued to receive the same standard care as they had in the 4 weeks before recruitment into the evaluation increases the likelihood that the clinical outcomes observed here can be attributed to the haemoglobin spray. Topical haemoglobin shows promise in terms of its ability to accelerate healing in chronic pressure ulcers. 
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